Expected Cost Savings From Low-Dose Computed Tomography Scan Screening for Lung Cancer in Alberta, Canada

INTRODUCTION: The expensive modern therapeutic regimens for advanced lung cancer (LC) stages have been recently approved. We evaluated whether low-dose computed tomography (LDCT) LC screening of high-risk Albertans is cost saving. METHODS: We used a decision analytical modeling technique with a heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanh, Nguyen Xuan, Pham, Truong-Minh, Waye, Arianna, Tremblay, Alain, Yang, Huiming, Dean, Michelle L., Wasylak, Tracy, Sangha, Randeep, Stewart, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234227/
https://www.ncbi.nlm.nih.gov/pubmed/35769390
http://dx.doi.org/10.1016/j.jtocrr.2022.100350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234227/
https://www.ncbi.nlm.nih.gov/pubmed/35769390
http://dx.doi.org/10.1016/j.jtocrr.2022.100350

Ejemplares similares